EMA Authorised: Ivabradine Accord (ivabradine hydrochloride) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Ivabradine Accord (ivabradine hydrochloride) from Accord Healthcare S.L.U. for the treatment of angina pectoris and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Heart Failure

Drugs mentioned

• Ivabradine Accord (ivabradine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Angina Pectoris;Heart Failure. MAH: Accord Healthcare S.L.U.. Decision date: 31/08/2023